Back to Authors

Jin, Xiaoping

0009-0006-1902-1962

A5112681049

Mayo Clinic

MedImmune, Gaithersburg, MD;

Citations 1

Safety and efficacy of durvalumab (MEDI4736), a PD-L1 antibody, in urothelial bladder cancer.

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 4502-4502

10.1200/jco.2016.34.15_suppl.4502